Global C-reactive protein Testing Market Report

Global C-reactive protein Testing Market Analysis, Market Size, Application, Analysis, Regional Outlook, Competitive Strategies and Forecasts, 2015 to 2022

Format: PDF  |  Report ID: GVR1956

Rising prevalence of coronary heart diseases attributed to the narrowing of the coronary arteries due to fat deposition on the artery walls is expected to drive global C-reactive protein testing market. Additionally, non-controllable factors that contribute to increasing prevalence of coronary heart diseases such as family background and medical histories are also expected to drive the C-reactive protein testing market. Furthermore, growing geriatric population, which is prone to medical conditions such as high blood pressure coupled with rising awareness pertaining to C-reactive protein test for the diagnosis of cancer, cardiovascular diseases, and arthritis is expected to boost usage rates over the forecast period. Moreover, growing population with sedentary lifestyle and increasing incidences of diabetes mellitus are also some factors boosting market growth. However, lack of awareness regarding C-reactive protein tests compared to other blood tests amongst healthcare practitioners is a factor that is expected to impede the market growth.

Based on types of assays, the C-reactive protein testing market is segmented into Enzyme Linked Immuno Sorbet Assay (ELISA), Chemiluminesence immunoassay (CLIA), Immunoturbidimetric assays, and High-sensitivity C-reactive protein (hsCRP) assay. In 2014, High-sensitivity C-reactive protein (hsCRP) assay type was one of the highest revenue generating assay type. Key factors attributing to its large share include its ability to produce effective & accurate results even at low level of CRP in blood plasma. Moreover, rising prevalence of Endometriosis among women and increasing awareness regarding hsCRP assay being used as a marker for cardiac disorders are few factors that are expected to drive the growth of hsCRP assay. Furthermore, increasing demand for cost-effective, highly sensitive & specific diagnostic techniques among patients are expected to boost usage rates. ELISA in CRP testing market is expected to be one of the fastest growing markets over the forecast period, owing to increasing awareness regarding ELISA techniques among healthcare professionals. On the basis of application, the market is segmented into cancer, inflammatory bowel disease, rheumatoid arthritis, surgeries, diseases of immune system (Lupus), and cardiovascular diseases. In 2014, cardiovascular application of C-reactive protein tests was amongst one of the highest revenue generating application area of the market. Key factors attributing to its large share include growing prevalence of cardiovascular diseases and increasing population with unhealthy lifestyles such as consumption of processed food, lack of physical activities, and increasing alcohol consumption. Furthermore, increasing exposure to environmental factors such as second hand tobacco consumption and rising air pollution are expected to drive the C-reactive protein testing market over the period of seven years. Additionally, C-reactive protein tests are widely used in cancer diagnosis and other inflammatory diseases. Key factors that are expected to boost the cancer diagnosis and other inflammatory diseases segment include increasing incidences of cancer, which can be attributed to the increasing exposure to carcinogenic elements and genetic mutations. Furthermore, increasing population with weight issues and less consumption of anti inflammatory diet are also responsible for spurring the market growth.

North America, Europe, MEA, Asia Pacific, and Latin America are the key region markets included in the study. In 2014, North America accounted for the largest market share in terms of revenue owing to rising demand for accurate and rapid diagnostic tools and increasing need to detect, diagnose, and manage various types of cancers and cardiovascular diseases. However, Asia Pacific is expected to be the fastest growing regions of C-reactive protein testing market. Constantly improving healthcare infrastructure, favorable government initiatives pertaining to the development of novel diagnostic techniques to fight cancer and cardiovascular diseases, and economic development in the region are factors attributing to the region’s rapid growth. Increasing use of C-reactive protein in osteomyetitis, post-surgical infection, and auto immune diseases are factors that are expected to drive the growth of C-reactive protein testing market.

Key players of C reactive protein testing market include Roche Diagnostics, Randox, EMD Millipore, Quest Diagnostics, Abaxis Inc., and Life technologies.                                                      

 

Key questions answered by the report
Request for Customization

Choose License Type:

Single User - $4,950
Multi User - $7,950
Enterprise User - $9,950

Special Pricing & Discounts

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA